# Study of Human Umbilical Cord Mesenchymal Stem Cell in Patients With Cirrhosis Due to Hepatitis B (Compensation Stage)

> **NCT05507762** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Renmin Hospital of Wuhan University** · enrollment: 20 (estimated)

## Conditions studied

- Cirrhosis Due to Hepatitis B

## Interventions

- **BIOLOGICAL:** UC-MSCs
- **BIOLOGICAL:** Saline solution

## Key facts

- **NCT ID:** NCT05507762
- **Lead sponsor:** Renmin Hospital of Wuhan University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-20
- **Primary completion:** 2023-07-20
- **Final completion:** 2023-08-20
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-08-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05507762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05507762, "Study of Human Umbilical Cord Mesenchymal Stem Cell in Patients With Cirrhosis Due to Hepatitis B (Compensation Stage)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05507762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*